Topical Doxepin for Radiation-induced Dermatitis
NCT02447211
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Doxepin cream 5%
OTHER:
Placebo
Sponsor
Isfahan University of Medical Sciences